207 related articles for article (PubMed ID: 19001256)
1. Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder.
Kumar N; Sandroni P; Steensma DP; Luthra HS; Habermann TM
Neurology; 2008 Nov; 71(20):1644-5. PubMed ID: 19001256
[No Abstract] [Full Text] [Related]
2. Methotrexate-associated lymphoproliferative disorder arising in a patient with adult Still's disease.
Tanaka A; Shigematsu H; Kojima M; Sakashita H; Kusama K
J Oral Maxillofac Surg; 2008 Jul; 66(7):1492-5. PubMed ID: 18571037
[No Abstract] [Full Text] [Related]
3. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
4. [2-year complete remission after withdrawal of methotrexate in a rectal methotrexate-associated diffuse large B-cell lymphoma].
Ogasawara T; Kimura A; Yasuyama M; Ohtuka K; Aiba M; Kawauchi K
Rinsho Ketsueki; 2007 Jun; 48(6):485-90. PubMed ID: 17633096
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
Maruani A; Wierzbicka E; Machet MC; Abdallah-Lotf M; de Muret A; Machet L
J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S69-71. PubMed ID: 17938029
[TBL] [Abstract][Full Text] [Related]
6. [Methotrexate-associated lymphoproliferative disorder].
Kaneko Y
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):174-178. PubMed ID: 28747604
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin.
Clarke LE; Junkins-Hopkins J; Seykora JT; Adler DJ; Elenitsas R
J Am Acad Dermatol; 2007 Apr; 56(4):686-90. PubMed ID: 17141365
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and rofecoxib: idiosyncratic reaction or pharmacogenetics?
Vincent S; Slease RB; Rocca PV
Del Med J; 2002 Dec; 74(12):469-73. PubMed ID: 15595320
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-related MTX-LPD in rheumatoid arthritis patients exhibits a viral pattern of the CD64 and CD35 expression on neutrophils: three case reports.
Mokuda S; Miyazaki T; Saeki Y; Masumoto J; Kanno M; Takasugi K
Mod Rheumatol; 2015 Jan; 25(1):166-8. PubMed ID: 24499448
[No Abstract] [Full Text] [Related]
10. CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
Hatachi S; Kunitomi A; Aozasa K; Yagita M
Mod Rheumatol; 2010 Oct; 20(5):500-5. PubMed ID: 20437072
[TBL] [Abstract][Full Text] [Related]
11. [Case report; a case of methotrexate-associated lymphoproliferative disorders caused with multiple lung nodules].
Ota H; Koyama N; Nakamura A; Matsuda M; Yamamoto Y; Tomoda K; Yoshikawa M; Kimura H; Enomoto Y; Obayashi C
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2676-8. PubMed ID: 24400548
[No Abstract] [Full Text] [Related]
12. Methotrexate-associated lymphoproliferative disorder mimicking pyocyanic ecthyma gangrenosum in a patient with rheumatoid arthritis.
Inuzuka K; Endo Y; Kato M; Fujisawa A; Tanioka M; Kabashima K; Tsukamoto H; Sonobe J; Bessho K; Miyachi Y
Eur J Dermatol; 2013; 23(3):418-9. PubMed ID: 23783770
[No Abstract] [Full Text] [Related]
13. EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment.
Chim CS; Pang YY; Ooi GC; Mok MY; Shek TW
Haematologica; 2006 Aug; 91(8 Suppl):ECR31. PubMed ID: 16923515
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J
J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid arthritis.
Shimura C; Satoh T; Takayama K; Yokozeki H
J Am Acad Dermatol; 2009 Jul; 61(1):126-9. PubMed ID: 19539849
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-associated lymphoproliferative disorder presenting as disseminated malignancy.
Joannides AJ; El-Shaboury H; Guirguis R; Fasler JJ; Rajagopal V
Rheumatology (Oxford); 2011 Oct; 50(10):1927-8. PubMed ID: 21719419
[No Abstract] [Full Text] [Related]
17. Reversible methotrexate associated lymphoproliferative disease evolving into Hodgkin's disease.
Moseley AC; Lindsley HB; Skikne BS; Tawfik O
J Rheumatol; 2000 Mar; 27(3):810-3. PubMed ID: 10743830
[TBL] [Abstract][Full Text] [Related]
18. Right bundle branch block induced by low-dose methotrexate in a patient with rheumatoid arthritis.
Thonhofer R; Kriessmayr M; Thonhofer U; Wipfler E; Uitz E; Bahadori B
Scand J Rheumatol; 2007; 36(3):241-2. PubMed ID: 17657685
[No Abstract] [Full Text] [Related]
19. Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease.
Inokuma S; Kono H; Kohno Y; Hiramatsu K; Ito K; Shiratori K; Yamazaki J; Nakayama H; Shoda H; Tanaka Y
Ann Rheum Dis; 2006 Aug; 65(8):1113-4. PubMed ID: 16837494
[No Abstract] [Full Text] [Related]
20. Long-term remission of an EBV-positive B cell lymphoproliferative disorder associated with rheumatoid arthritis under methotrexate with anti-CD20 monoclonal antibody (Rituximab) monotherapy.
Kelaïdi C; Tulliez M; Lecoq-Lafon C; Pham XV; Kahan A; Dreyfus F; Bouscary D
Leukemia; 2002 Oct; 16(10):2173-4. PubMed ID: 12357380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
